Sanofi: Sarclisa Recommended for EU Approval by CHMP to Treat Transplant-Ineligible Newly Diagnosed Multiple Myeloma
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma
Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...
Banks to Pitch Roughly €11 Billion Buyout Debt for Grifols
Banks are getting ready to submit final offers to Brookfield Asset Management for a debt package of about €11 billion ($11.6 ...
BioPharma Dive52m
Jennie Taveras Joins STO Building Group to Lead Life Sciences Sector
Life sciences expert Jennie Taveras has joined STO Building Group to lead the company’s growth in the life sciences sector ...
The Pharma Letter42m
Merck & Co wades into PD-1/VEGF space via deal with LaNova Medicines
Merck & Co has entered into an exclusive global license to develop, manufacture and commercialize LM-299 from China-based ...
The Pharma Letter44m
Positive results for Microbion’s new diabetic foot ulcer drug
Microbion's Phase II trial of pravibismane for diabetic foot ulcer infections showed strong safety and positive efficacy ...